Consumer Research
Seed Junky Partners with Trulieve to Bring Premium Genetics to Pennsylvania
LOS ANGELES – Seed Junky Genetics announced the expansion, confirming ...
Cantourage Locks In Green Karat as EU-GMP Certified Supplier
BERLIN – Cantourage Group SE has announced an expanded supply ...
DEA Judge Stalls Cannabis Rescheduling Over Process Gaps Report
WASHINGTON – Federal adult-use Cannabis rescheduling is at a standstill. Again. This time, the trigger is a government audit that found the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) have long ...
NCS Analytics Partners with Cannabiz Credit Association on Lending Data
DENVER – NCS Analytics and Cannabiz Credit Association have entered an exclusive agreement that links payment histories to existing operational risk tools. The arrangement targets lenders evaluating licensed Cannabis businesses and aims to give them ...
Vireo Growth Ties Ohio Note to Shares via Put/Call Agreement
MINNEAPOLIS – Vireo Growth Inc. announced that it entered a Put/Call Agreement with Battle Green Holdings SR LLC – the current holder of a promissory note originally issued by BG Ohio SPV LLC. The principal ...
FTSE Canada All Cap Index Adds Curaleaf to Its Ranks
STAMFORD – Curaleaf Holdings Inc. confirmed that it has been added to the FTSE Canada All Cap Index, effective after the close of trading on September 18, 2026. Maintained by FTSE Russell, the index tracks ...
Canopy Growth Powers European Expansion with UK Entry
SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...
Canna Cabana Takes the Widest Lead Yet in Canadian Cannabis Retail
CALGARY – A Retailer Insights Report compiled by Rebel & Thorn, a media and marketing consultancy, shows Canna Cabana extending its position across Canadian Cannabis retail in Q3 2026. The findings span brand awareness, primary ...
Trulieve Earns Its Spot on the S&P Indices
TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...
New Menopause Guide Unlocks the Power of Major Cannabinoids
HONOLULU – As demand for Cannabis and hemp-based wellness products aimed at midlife women continues to grow, a new comprehensive guide by Rare Cannabinoid Company is pushing back against the one-size-fits-all framing that has come ...
Kasvu Therapeutics Raises €30M for Next Generation Neuroplasticity Drugs
HELSINKI – Kasvu Therapeutics, a three-year-old spinout from the University of Helsinki, closed a €30 million Series A to advance its lead compound toward clinical development. The round was led by Hadean Ventures, with participation ...
Aurora Hits Curaleaf with Regulatory Complaint Over Hostile Bid
EDMONTON – Aurora Cannabis Inc. filed an application with the Alberta Securities Commission (ASC), asking the regulator to order Curaleaf Holdings Inc. to correct several alleged deficiencies in its hostile takeover bid circular – or ...
MariMed Reports Q1 2026 Financial Results
NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and ...
Grown Rogue Reports Q1 2026 Financial Results
MEDFORD – Grown Rogue International Inc. delivered solid top-line gains in the opening months of 2026, underscoring its push into select markets while managing pressures in more established ones. The company, known for its focus ...
Jushi Reports Q1 2026 Financial Results
BOCA RATON – Jushi Holdings Inc. delivered a quarter of steady operational progress while facing ongoing industry pressures. The multi-state operator recorded year-on-year improvements in revenue and profitability metrics, and completed a significant refinancing of ...
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter results for 2026, revealing a company focused on operational tweaks while navigating softer sales in a competitive Cannabis market. The multi-state operator, active across retail ...
Organigram Reports Q2 Fiscal 2026 Results
TORONTO – Organigram Global Inc. released its financial results, marking a quarter shaped by shifts in consumer preferences and execution issues in key categories. The Canadian producer, known for holding the top market share position ...
Cannabis 3.0: From Getting High to Getting Clinical
NEW YORK-Cannabis is entering a new phase, and this one is about much more than consumption. For decades, Cannabis was trapped in prohibition and treated mainly as a legal problem. Then came commercialization, when Cannabis ...
Vireo Growth Reports Q1 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a ...
Village Farms Reports Q1 2026 Financial Results
VANCOUVER – Village Farms International Inc., known for its large-scale greenhouse operations, reported gains in revenue and profitability driven largely by exports. Consolidated net sales climbed 27% year-over-year to $50.2 million, with net income attributable ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside ...
Target Expands Hemp-Derived THC Beverage Sales Area
NEW YORK – Target is broadening its reach in the hemp-derived THC beverage category, adding the products to more than 300 stores across Florida, Texas and parts of Illinois. The mass retailer confirmed the move ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at ...
High Tide Scores Big in Germany Through Remexian Distribution
CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German subsidiary, Remexian Pharma GmbH, distributed 7.6 tons of medical Cannabis flower into the German market during the second fiscal quarter ended April 30, 2026 – ...
